BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rye DB, Bliwise DL, Parker K, Trotti LM, Saini P, Fairley J, Freeman A, Garcia PS, Owens MJ, Ritchie JC, Jenkins A. Modulation of vigilance in the primary hypersomnias by endogenous enhancement of GABAA receptors. Sci Transl Med 2012;4:161ra151. [PMID: 23175709 DOI: 10.1126/scitranslmed.3004685] [Cited by in Crossref: 104] [Cited by in F6Publishing: 81] [Article Influence: 11.6] [Reference Citation Analysis]
Number Citing Articles
1 Chander D, García PS, MacColl JN, Illing S, Sleigh JW. Electroencephalographic variation during end maintenance and emergence from surgical anesthesia. PLoS One 2014;9:e106291. [PMID: 25264892 DOI: 10.1371/journal.pone.0106291] [Cited by in Crossref: 58] [Cited by in F6Publishing: 51] [Article Influence: 7.3] [Reference Citation Analysis]
2 Dauvilliers Y, Barateau L. Narcolepsy and Other Central Hypersomnias. Continuum (Minneap Minn) 2017;23:989-1004. [PMID: 28777172 DOI: 10.1212/CON.0000000000000492] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
3 Arnulf I, Leu-semenescu S, Dodet P. Precision Medicine for Idiopathic Hypersomnia. Sleep Medicine Clinics 2019;14:333-50. [DOI: 10.1016/j.jsmc.2019.05.007] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
4 Sowa NA. Idiopathic Hypersomnia and Hypersomnolence Disorder: A Systematic Review of the Literature. Psychosomatics 2016;57:152-64. [DOI: 10.1016/j.psym.2015.12.006] [Cited by in Crossref: 18] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
5 Ricciardi L, De Nigris F, Specchia A, Fasano A. Homotaurine in Parkinson's disease. Neurol Sci 2015;36:1581-7. [PMID: 25894843 DOI: 10.1007/s10072-015-2201-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
6 Landzberg D, Trotti LM. Is Idiopathic Hypersomnia a Circadian Rhythm Disorder? Curr Sleep Med Rep 2019;5:201-6. [PMID: 33312847 DOI: 10.1007/s40675-019-00154-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
7 Goh ET, Andersen ML, Morgan MY, Gluud LL. Flumazenil versus placebo or no intervention for people with cirrhosis and hepatic encephalopathy. Cochrane Database Syst Rev 2017;7:CD002798. [PMID: 28745801 DOI: 10.1002/14651858.CD002798.pub3] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
8 Liu C, Chung M. Genetics and epigenetics of circadian rhythms and their potential roles in neuropsychiatric disorders. Neurosci Bull 2015;31:141-59. [PMID: 25652815 DOI: 10.1007/s12264-014-1495-3] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 3.9] [Reference Citation Analysis]
9 Christian CA, Herbert AG, Holt RL, Peng K, Sherwood KD, Pangratz-Fuehrer S, Rudolph U, Huguenard JR. Endogenous positive allosteric modulation of GABA(A) receptors by diazepam binding inhibitor. Neuron 2013;78:1063-74. [PMID: 23727119 DOI: 10.1016/j.neuron.2013.04.026] [Cited by in Crossref: 58] [Cited by in F6Publishing: 54] [Article Influence: 6.4] [Reference Citation Analysis]
10 Berkowski JA, Shelgikar AV. Disorders of Excessive Daytime Sleepiness Including Narcolepsy and Idiopathic Hypersomnia. Sleep Medicine Clinics 2016;11:365-78. [DOI: 10.1016/j.jsmc.2016.04.005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
11 Donelson NC, Sanyal S. Use of Drosophila in the investigation of sleep disorders. Exp Neurol 2015;274:72-9. [PMID: 26160555 DOI: 10.1016/j.expneurol.2015.06.024] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
12 Johansson M, Månsson M, Lins LE, Scharschmidt B, Doverskog M, Bäckström T. GR3027 reversal of neurosteroid-induced, GABA-A receptor-mediated inhibition of human brain function: an allopregnanolone challenge study. Psychopharmacology (Berl) 2018;235:1533-43. [PMID: 29492615 DOI: 10.1007/s00213-018-4864-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
13 Dauvilliers Y, Evangelista E, Lopez R, Barateau L, Jaussent I, Cens T, Rousset M, Charnet P. Absence of γ-aminobutyric acid-a receptor potentiation in central hypersomnolence disorders: GABA-A Receptor Potentiation. Ann Neurol 2016;80:259-68. [DOI: 10.1002/ana.24710] [Cited by in Crossref: 34] [Cited by in F6Publishing: 20] [Article Influence: 5.7] [Reference Citation Analysis]
14 Trotti LM, Ong JC, Plante DT, Friederich Murray C, King R, Bliwise DL. Disease symptomatology and response to treatment in people with idiopathic hypersomnia: initial data from the Hypersomnia Foundation registry. Sleep Med 2020;75:343-9. [PMID: 32950878 DOI: 10.1016/j.sleep.2020.08.034] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
15 Takahashi T, Noriaki S, Matsumura M, Li C, Takahashi K, Nishino S. Advances in pharmaceutical treatment options for narcolepsy. Expert Opinion on Orphan Drugs 2018;6:597-610. [DOI: 10.1080/21678707.2018.1521267] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
16 Plante DT. Sleep propensity in psychiatric hypersomnolence: A systematic review and meta-analysis of multiple sleep latency test findings. Sleep Med Rev 2017;31:48-57. [PMID: 26883161 DOI: 10.1016/j.smrv.2016.01.004] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 4.2] [Reference Citation Analysis]
17 Zhang J, Han F. Sleepiness in Narcolepsy. Sleep Medicine Clinics 2017;12:323-30. [DOI: 10.1016/j.jsmc.2017.03.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
18 August J, Rosen D. Advances and Current Issues in Adolescent Sleep. Curr Pediatr Rep 2020;8:105-14. [DOI: 10.1007/s40124-020-00224-7] [Reference Citation Analysis]
19 Lopez R, Doukkali A, Barateau L, Evangelista E, Chenini S, Jaussent I, Dauvilliers Y. Test–Retest Reliability of the Multiple Sleep Latency Test in Central Disorders of Hypersomnolence. Sleep 2017;40. [DOI: 10.1093/sleep/zsx164] [Cited by in Crossref: 48] [Cited by in F6Publishing: 31] [Article Influence: 9.6] [Reference Citation Analysis]
20 Safavynia SA, Keating G, Speigel I, Fidler JA, Kreuzer M, Rye DB, Jenkins A, García PS. In Reply. Anesthesiology 2017;126:352-3. [PMID: 28098616 DOI: 10.1097/ALN.0000000000001446] [Reference Citation Analysis]
21 Scott PJ, Shao X, Desmond TJ, Hockley BG, Sherman P, Quesada CA, Frey KA, Koeppe RA, Kilbourn MR, Bohnen NI. Investigation of Proposed Activity of Clarithromycin at GABAA Receptors Using [(11)C]Flumazenil PET. ACS Med Chem Lett 2016;7:746-50. [PMID: 27563397 DOI: 10.1021/acsmedchemlett.5b00435] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
22 Lim MM, Szymusiak R. Neurobiology of Arousal and Sleep: Updates and Insights Into Neurological Disorders. Curr Sleep Medicine Rep 2015;1:91-100. [DOI: 10.1007/s40675-015-0013-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 1] [Article Influence: 1.4] [Reference Citation Analysis]
23 Barateau L, Lopez R, Dauvilliers Y. Clinical neurophysiology of CNS hypersomnias. Handb Clin Neurol 2019;161:353-67. [PMID: 31307613 DOI: 10.1016/B978-0-444-64142-7.00060-6] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
24 Pérez-Carbonell L, Leschziner G. Clinical update on central hypersomnias. J Thorac Dis 2018;10:S112-23. [PMID: 29445535 DOI: 10.21037/jtd.2017.10.161] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
25 Billiard M, Sonka K. Idiopathic hypersomnia. Sleep Medicine Reviews 2016;29:23-33. [DOI: 10.1016/j.smrv.2015.08.007] [Cited by in Crossref: 57] [Cited by in F6Publishing: 38] [Article Influence: 9.5] [Reference Citation Analysis]
26 Graef DM, Byars KC, Simakajornboon N, Dye TJ. Topical Review: A Biopsychosocial Framework for Pediatric Narcolepsy and Idiopathic Hypersomnia. J Pediatr Psychol 2020;45:34-9. [PMID: 31670813 DOI: 10.1093/jpepsy/jsz085] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
27 Materna L, Halfter H, Heidbreder A, Boentert M, Lippert J, Koch R, Young P. Idiopathic Hypersomnia Patients Revealed Longer Circadian Period Length in Peripheral Skin Fibroblasts. Front Neurol 2018;9:424. [PMID: 29930532 DOI: 10.3389/fneur.2018.00424] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
28 Hamper M, Cassano P, Lombard J. Treatment of Kleine-Levin Syndrome With Intranasal Photobiomodulation and Methylene Blue. Cureus 2021;13:e18596. [PMID: 34659921 DOI: 10.7759/cureus.18596] [Reference Citation Analysis]
29 Khan Z, Trotti LM. Central Disorders of Hypersomnolence: Focus on the Narcolepsies and Idiopathic Hypersomnia. Chest 2015;148:262-73. [PMID: 26149554 DOI: 10.1378/chest.14-1304] [Cited by in Crossref: 38] [Cited by in F6Publishing: 31] [Article Influence: 5.4] [Reference Citation Analysis]
30 Vringer M, Kornum BR. Emerging therapeutic targets for narcolepsy. Expert Opin Ther Targets 2021;:1-14. [PMID: 34402358 DOI: 10.1080/14728222.2021.1969361] [Reference Citation Analysis]
31 Uygun DS, Ye Z, Zecharia AY, Harding EC, Yu X, Yustos R, Vyssotski AL, Brickley SG, Franks NP, Wisden W. Bottom-Up versus Top-Down Induction of Sleep by Zolpidem Acting on Histaminergic and Neocortex Neurons. J Neurosci 2016;36:11171-84. [PMID: 27807161 DOI: 10.1523/JNEUROSCI.3714-15.2016] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
32 González M. Hipersomnia idiopática: desconocida y polimórfica. Revista Médica Clínica Las Condes 2021;32:584-90. [DOI: 10.1016/j.rmclc.2021.09.005] [Reference Citation Analysis]
33 Trotti LM, Saini P, Koola C, LaBarbera V, Bliwise DL, Rye DB. Flumazenil for the Treatment of Refractory Hypersomnolence: Clinical Experience with 153 Patients. J Clin Sleep Med 2016;12:1389-94. [PMID: 27568889 DOI: 10.5664/jcsm.6196] [Cited by in Crossref: 36] [Cited by in F6Publishing: 23] [Article Influence: 6.0] [Reference Citation Analysis]
34 Wang D, Kaneshwaran K, Lei G, Mostafa F, Wang J, Lecker I, Avramescu S, Xie Y, Chan NK, Fernandez-escobar A, Woo J, Chan D, Ramsey AJ, Sivak JM, Lee CJ, Bonin RP, Orser BA. Dexmedetomidine Prevents Excessive γ-Aminobutyric Acid Type A Receptor Function after Anesthesia. Anesthesiology 2018;129:477-89. [DOI: 10.1097/aln.0000000000002311] [Cited by in Crossref: 22] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
35 LaBarbera V, García PS, Bliwise DL, Trotti LM. Central Disorders of Hypersomnolence, Restless Legs Syndrome, and Surgery With General Anesthesia: Patient Perceptions. Front Hum Neurosci 2018;12:99. [PMID: 29615884 DOI: 10.3389/fnhum.2018.00099] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
36 Goh ET, Andersen ML, Morgan MY, Gluud LL. Flumazenil versus placebo or no intervention for people with cirrhosis and hepatic encephalopathy. Cochrane Database Syst Rev 2017;8:CD002798. [PMID: 28796283 DOI: 10.1002/14651858.CD002798.pub4] [Cited by in Crossref: 4] [Article Influence: 0.8] [Reference Citation Analysis]
37 Evangelista E, Lopez R, Dauvilliers Y. Update on treatment for idiopathic hypersomnia. Expert Opinion on Investigational Drugs 2018;27:187-92. [DOI: 10.1080/13543784.2018.1417385] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
38 Nevsimalova S, Susta M, Prihodova I, Horvat EM, Milata M, Sonka K. Idiopathic hypersomnia: a homogeneous or heterogeneous disease? Sleep Med 2021;80:86-91. [PMID: 33588261 DOI: 10.1016/j.sleep.2021.01.031] [Reference Citation Analysis]
39 Piantino JA, Iliff JJ, Lim MM. The Bidirectional Link Between Sleep Disturbances and Traumatic Brain Injury Symptoms: A Role for Glymphatic Dysfunction? Biol Psychiatry 2021:S0006-3223(21)01442-6. [PMID: 34481662 DOI: 10.1016/j.biopsych.2021.06.025] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
40 Schinkelshoek MS, Fronczek R, Lammers GJ. Update on the Treatment of Idiopathic Hypersomnia. Curr Sleep Medicine Rep 2019;5:207-14. [DOI: 10.1007/s40675-019-00158-7] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
41 Saini P, Rye DB. Hypersomnia. Sleep Medicine Clinics 2017;12:47-60. [DOI: 10.1016/j.jsmc.2016.10.013] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 2.6] [Reference Citation Analysis]
42 Farzampour Z, Reimer RJ, Huguenard J. Endozepines. Adv Pharmacol 2015;72:147-64. [PMID: 25600369 DOI: 10.1016/bs.apha.2014.10.005] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.5] [Reference Citation Analysis]
43 Kolb I, Stoy WA, Rousseau EB, Moody OA, Jenkins A, Forest CR. Cleaning patch-clamp pipettes for immediate reuse. Sci Rep 2016;6:35001. [PMID: 27725751 DOI: 10.1038/srep35001] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 4.3] [Reference Citation Analysis]
44 Evangelista E, Lopez R, Barateau L, Chenini S, Bosco A, Jaussent I, Dauvilliers Y. Alternative diagnostic criteria for idiopathic hypersomnia: A 32-hour protocol: Idiopathic Hypersomnia. Ann Neurol 2018;83:235-47. [DOI: 10.1002/ana.25141] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
45 Trotti LM. Waking up is the hardest thing I do all day: Sleep inertia and sleep drunkenness. Sleep Med Rev 2017;35:76-84. [PMID: 27692973 DOI: 10.1016/j.smrv.2016.08.005] [Cited by in Crossref: 65] [Cited by in F6Publishing: 51] [Article Influence: 10.8] [Reference Citation Analysis]
46 Brickley SG, Franks NP, Wisden W. Modulation of GABA A receptor function and sleep. Current Opinion in Physiology 2018;2:51-7. [DOI: 10.1016/j.cophys.2017.12.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
47 Plazzi G, Rye D, Vignatelli L, Riva R, Lugaresi E. Idiopathic recurrent stupor: Munchausen by proxy and medical litigation. Sleep 2014;37:211. [PMID: 24470710 DOI: 10.5665/sleep.3342] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
48 Shen Z, Wu P, Wang F, Xia Z, Deng Q, Nie T, Zhang S, Zheng H, Liu W, Lu J, Gao S, Yao X, Long L, Hu Z, Chen J. Gephyrin Palmitoylation in Basolateral Amygdala Mediates the Anxiolytic Action of Benzodiazepine. Biological Psychiatry 2019;85:202-13. [DOI: 10.1016/j.biopsych.2018.09.024] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
49 Moody OA, Talwar S, Jenkins MA, Freeman AA, Trotti LM, García PS, Bliwise D, Lynch JW, Cherson B, Hernandez EM, Feldman N, Saini P, Rye DB, Jenkins A. Rigor, reproducibility, and in vitro cerebrospinal fluid assays: The devil in the details. Ann Neurol 2017;81:904-7. [PMID: 28440033 DOI: 10.1002/ana.24940] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
50 Drakatos P, Leschziner GD. Update on hypersomnias of central origin. Curr Opin Pulm Med 2014;20:572-80. [PMID: 25165990 DOI: 10.1097/MCP.0000000000000098] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
51 Trotti LM. Central Disorders of Hypersomnolence. Continuum (Minneap Minn) 2020;26:890-907. [PMID: 32756227 DOI: 10.1212/CON.0000000000000883] [Reference Citation Analysis]
52 Safavynia SA, Keating G, Speigel I, Fidler JA, Kreuzer M, Rye DB, Jenkins A, García PS. Effects of γ-Aminobutyric Acid Type A Receptor Modulation by Flumazenil on Emergence from General Anesthesia. Anesthesiology 2016;125:147-58. [PMID: 27111534 DOI: 10.1097/ALN.0000000000001134] [Cited by in Crossref: 25] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
53 Trotti LM, Bliwise DL, Rye DB. Further experience using clarithromycin in patients with Kleine-Levin syndrome. J Clin Sleep Med 2014;10:457-8. [PMID: 24733995 DOI: 10.5664/jcsm.3634] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
54 Billiard M. Hypersomnias Other Than Narcolepsy: Differential Diagnosis. In: Goswami M, Thorpy MJ, Pandi-perumal S, editors. Narcolepsy. Cham: Springer International Publishing; 2016. pp. 129-46. [DOI: 10.1007/978-3-319-23739-8_10] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
55 Wickwire EM, Williams SG, Roth T, Capaldi VF, Jaffe M, Moline M, Motamedi GK, Morgan GW, Mysliwiec V, Germain A, Pazdan RM, Ferziger R, Balkin TJ, MacDonald ME, Macek TA, Yochelson MR, Scharf SM, Lettieri CJ. Sleep, Sleep Disorders, and Mild Traumatic Brain Injury. What We Know and What We Need to Know: Findings from a National Working Group. Neurotherapeutics 2016;13:403-17. [PMID: 27002812 DOI: 10.1007/s13311-016-0429-3] [Cited by in Crossref: 65] [Cited by in F6Publishing: 64] [Article Influence: 13.0] [Reference Citation Analysis]
56 Evangelista E, Rassu AL, Barateau L, Lopez R, Chenini S, Jaussent I, Dauvilliers Y. Characteristics associated with hypersomnia and excessive daytime sleepiness identified by extended polysomnography recording. Sleep 2021;44:zsaa264. [PMID: 33249509 DOI: 10.1093/sleep/zsaa264] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
57 Rugama AD, Desautels A, Montplaisir J, Carrier J, Thompson C, Blais H, Lina J, Gosselin N. Electroencephalographic Markers of Idiopathic Hypersomnia: Where We are and Where We are Going. Curr Sleep Medicine Rep 2020;6:101-10. [DOI: 10.1007/s40675-020-00173-z] [Reference Citation Analysis]
58 Leu-semenescu S, Louis P, Arnulf I. Benefits and risk of sodium oxybate in idiopathic hypersomnia versus narcolepsy type 1: a chart review. Sleep Medicine 2016;17:38-44. [DOI: 10.1016/j.sleep.2015.10.005] [Cited by in Crossref: 34] [Cited by in F6Publishing: 23] [Article Influence: 5.7] [Reference Citation Analysis]
59 Keating G, Bliwise DL, Saini P, Rye DB, Trotti LM. Hypocretin measurement: shelf age of radioimmunoassay kit, but not freezer time, influences assay variability. Scand J Clin Lab Invest 2017;77:390-3. [PMID: 28537447 DOI: 10.1080/00365513.2017.1325928] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
60 Maski KP, Colclasure A, Little E, Steinhart E, Scammell TE, Navidi W, Diniz Behn C. Stability of nocturnal wake and sleep stages defines central nervous system disorders of hypersomnolence. Sleep 2021;44:zsab021. [PMID: 33512510 DOI: 10.1093/sleep/zsab021] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
61 Boucetta S, Montplaisir J, Zadra A, Lachapelle F, Soucy JP, Gravel P, Dang-Vu TT. Altered Regional Cerebral Blood Flow in Idiopathic Hypersomnia. Sleep 2017;40. [PMID: 28958044 DOI: 10.1093/sleep/zsx140] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
62 Leu-semenescu S, Nittur N, Golmard J, Arnulf I. Effects of pitolisant, a histamine H3 inverse agonist, in drug-resistant idiopathic and symptomatic hypersomnia: a chart review. Sleep Medicine 2014;15:681-7. [DOI: 10.1016/j.sleep.2014.01.021] [Cited by in Crossref: 47] [Cited by in F6Publishing: 33] [Article Influence: 5.9] [Reference Citation Analysis]
63 Kelty E, Martyn V, O'Neil G, Hulse G. Use of subcutaneous flumazenil preparations for the treatment of idiopathic hypersomnia: A case report. J Psychopharmacol 2014;28:703-6. [PMID: 24554692 DOI: 10.1177/0269881114523865] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
64 Dauvilliers Y, Charnet P. Reply to "Rigor, reproducibility and in vitro CSF assays: The devil in the details". Ann Neurol 2017;81:907-10. [PMID: 28439988 DOI: 10.1002/ana.24939] [Reference Citation Analysis]
65 Hoffmann E, Nomikos GG, Kaul I, Raines S, Wald J, Bullock A, Sankoh AJ, Doherty J, Kanes SJ, Colquhoun H. SAGE-217, A Novel GABAA Receptor Positive Allosteric Modulator: Clinical Pharmacology and Tolerability in Randomized Phase I Dose-Finding Studies. Clin Pharmacokinet 2020;59:111-20. [PMID: 31338688 DOI: 10.1007/s40262-019-00801-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 12.0] [Reference Citation Analysis]
66 Dauvilliers Y, Evangelista E, Barateau L, Lopez R, Chenini S, Delbos C, Beziat S, Jaussent I. Measurement of symptoms in idiopathic hypersomnia: The Idiopathic Hypersomnia Severity Scale. Neurology 2019;92:e1754-62. [DOI: 10.1212/wnl.0000000000007264] [Cited by in Crossref: 11] [Cited by in F6Publishing: 1] [Article Influence: 3.7] [Reference Citation Analysis]
67 Liu KK, Bartsch RP, Lin A, Mantegna RN, Ivanov PCh. Plasticity of brain wave network interactions and evolution across physiologic states. Front Neural Circuits 2015;9:62. [PMID: 26578891 DOI: 10.3389/fncir.2015.00062] [Cited by in Crossref: 71] [Cited by in F6Publishing: 53] [Article Influence: 10.1] [Reference Citation Analysis]
68 de Biase S, Nilo A, Gigli GL, Valente M. Investigational therapies for the treatment of narcolepsy. Expert Opin Investig Drugs 2017;26:953-63. [PMID: 28726523 DOI: 10.1080/13543784.2017.1356819] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
69 Lopez R, Arnulf I, Drouot X, Lecendreux M, Dauvilliers Y. French consensus. Management of patients with hypersomnia: Which strategy? Revue Neurologique 2017;173:8-18. [DOI: 10.1016/j.neurol.2016.09.018] [Cited by in Crossref: 22] [Cited by in F6Publishing: 11] [Article Influence: 4.4] [Reference Citation Analysis]
70 Piantino J, Lim MM, Newgard CD, Iliff J. Linking Traumatic Brain Injury, Sleep Disruption and Post-Traumatic Headache: a Potential Role for Glymphatic Pathway Dysfunction. Curr Pain Headache Rep 2019;23. [DOI: 10.1007/s11916-019-0799-4] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 7.7] [Reference Citation Analysis]
71 Plante DT, Cook JD, Prairie ML. Multimodal assessment increases objective identification of hypersomnolence in patients referred for multiple sleep latency testing. J Clin Sleep Med 2020;16:1241-8. [PMID: 32267229 DOI: 10.5664/jcsm.8470] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
72 Bichler EK, Elder CC, García PS. Clarithromycin increases neuronal excitability in CA3 pyramidal neurons through a reduction in GABAergic signaling. J Neurophysiol 2017;117:93-103. [PMID: 27733592 DOI: 10.1152/jn.00134.2016] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
73 Nishimon S, Yamaguchi M, Muraki H, Sakai N, Nishino S. Intraperitoneal injection of ginkgolide B, a major active compound of Ginkgo biloba, dose-dependently increases the amount of wake and decreases non-rapid eye movement sleep in C57BL/6 mice. Neurosci Lett 2020;722:134832. [PMID: 32050100 DOI: 10.1016/j.neulet.2020.134832] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
74 Trotti LM. Idiopathic Hypersomnia. Sleep Med Clin 2017;12:331-44. [PMID: 28778232 DOI: 10.1016/j.jsmc.2017.03.009] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 3.4] [Reference Citation Analysis]
75 Pizza F, Filardi M, Moresco M, Antelmi E, Vandi S, Neccia G, Mazzoni A, Plazzi G. Excessive daytime sleepiness in narcolepsy and central nervous system hypersomnias. Sleep Breath 2020;24:605-14. [DOI: 10.1007/s11325-019-01867-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
76 Trotti LM, Bliwise DL. Brain MRI findings in patients with idiopathic hypersomnia. Clin Neurol Neurosurg 2017;157:19-21. [PMID: 28376374 DOI: 10.1016/j.clineuro.2017.03.010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
77 Trotti LM, Becker LA, Friederich Murray C, Hoque R. Medications for daytime sleepiness in individuals with idiopathic hypersomnia. Cochrane Database Syst Rev 2021;5:CD012714. [PMID: 34031871 DOI: 10.1002/14651858.CD012714.pub2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
78 Wang P, Li Q, Dong X, An H, Li J, Zhao L, Yan H, Aritake K, Huang Z, Strohl KP, Urade Y, Zhang J, Han F. Lipocalin-type prostaglandin D synthase levels increase in patients with narcolepsy and idiopathic hypersomnia. Sleep 2021;44:zsaa234. [PMID: 33175978 DOI: 10.1093/sleep/zsaa234] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
79 Islam MT, Ali ES, Uddin SJ, Shaw S, Islam MA, Ahmed MI, Chandra Shill M, Karmakar UK, Yarla NS, Khan IN, Billah MM, Pieczynska MD, Zengin G, Malainer C, Nicoletti F, Gulei D, Berindan-neagoe I, Apostolov A, Banach M, Yeung AW, El-demerdash A, Xiao J, Dey P, Yele S, Jóźwik A, Strzałkowska N, Marchewka J, Rengasamy KR, Horbańczuk J, Kamal MA, Mubarak MS, Mishra SK, Shilpi JA, Atanasov AG. Phytol: A review of biomedical activities. Food and Chemical Toxicology 2018;121:82-94. [DOI: 10.1016/j.fct.2018.08.032] [Cited by in Crossref: 59] [Cited by in F6Publishing: 35] [Article Influence: 14.8] [Reference Citation Analysis]
80 Rezvanian E, Watson NF. Kleine-levin syndrome treated with clarithromycin. J Clin Sleep Med 2013;9:1211-2. [PMID: 24235906 DOI: 10.5664/jcsm.3176] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
81 Barateau L, Jaussent I, Roeser J, Ciardiello C, Kilduff TS, Dauvilliers Y. Cerebrospinal fluid monoamine levels in central disorders of hypersomnolence. Sleep 2021;44:zsab012. [PMID: 33476396 DOI: 10.1093/sleep/zsab012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
82 Davis KC, Raizen DM. A mechanism for sickness sleep: lessons from invertebrates. J Physiol 2017;595:5415-24. [PMID: 28028818 DOI: 10.1113/JP273009] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 2.2] [Reference Citation Analysis]
83 Trotti LM, Saini P, Freeman AA, Bliwise DL, García PS, Jenkins A, Rye DB. Improvement in daytime sleepiness with clarithromycin in patients with GABA-related hypersomnia: Clinical experience. J Psychopharmacol 2014;28:697-702. [DOI: 10.1177/0269881113515062] [Cited by in Crossref: 37] [Cited by in F6Publishing: 28] [Article Influence: 4.1] [Reference Citation Analysis]
84 Trotti LM, Saini P, Bliwise DL, Freeman AA, Jenkins A, Rye DB. Clarithromycin in γ-aminobutyric acid-Related hypersomnolence: A randomized, crossover trial. Ann Neurol 2015;78:454-65. [PMID: 26094838 DOI: 10.1002/ana.24459] [Cited by in Crossref: 59] [Cited by in F6Publishing: 39] [Article Influence: 8.4] [Reference Citation Analysis]
85 Leu-semenescu S, Quera-salva M, Dauvilliers Y. French consensus. Idiopathic hypersomnia: Investigations and follow-up. Revue Neurologique 2017;173:32-7. [DOI: 10.1016/j.neurol.2016.09.015] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 1.4] [Reference Citation Analysis]
86 Kelz MB, García PS, Mashour GA, Solt K. Escape From Oblivion: Neural Mechanisms of Emergence From General Anesthesia. Anesth Analg 2019;128:726-36. [PMID: 30883418 DOI: 10.1213/ANE.0000000000004006] [Cited by in Crossref: 22] [Cited by in F6Publishing: 9] [Article Influence: 7.3] [Reference Citation Analysis]
87 Ulke C, Huang J, Schwabedal JTC, Surova G, Mergl R, Hensch T. Coupling and dynamics of cortical and autonomic signals are linked to central inhibition during the wake-sleep transition. Sci Rep 2017;7:11804. [PMID: 28924202 DOI: 10.1038/s41598-017-09513-6] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
88 He K, Kapur VK. Sleep-Disordered Breathing and Excessive Daytime Sleepiness. Sleep Med Clin 2017;12:369-82. [PMID: 28778235 DOI: 10.1016/j.jsmc.2017.03.010] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 4.8] [Reference Citation Analysis]
89 Trotti LM, Staab BA, Rye DB. Test-retest reliability of the multiple sleep latency test in narcolepsy without cataplexy and idiopathic hypersomnia. J Clin Sleep Med 2013;9:789-95. [PMID: 23946709 DOI: 10.5664/jcsm.2922] [Cited by in Crossref: 102] [Cited by in F6Publishing: 76] [Article Influence: 11.3] [Reference Citation Analysis]
90 Yuan H, Low CM, Moody OA, Jenkins A, Traynelis SF. Ionotropic GABA and Glutamate Receptor Mutations and Human Neurologic Diseases. Mol Pharmacol 2015;88:203-17. [PMID: 25904555 DOI: 10.1124/mol.115.097998] [Cited by in Crossref: 112] [Cited by in F6Publishing: 109] [Article Influence: 16.0] [Reference Citation Analysis]
91 Peter-derex L. Patologie del sonno. EMC - Neurologia 2019;19:1-17. [DOI: 10.1016/s1634-7072(19)42492-6] [Reference Citation Analysis]